Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PERJETA vs PEXIDARTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PERJETA vs PEXIDARTINIB: Safety Overview

Metric PERJETA PEXIDARTINIB
Total FAERS Reports 228 970
Deaths Reported 44 17
Death Rate 19.3% 1.8%
Hospitalizations 80 91
Average Patient Age 57.8 yrs 44.9 yrs
% Female Patients N/A 63.4%
FDA Approval Date N/A Aug 2, 2019
Manufacturer N/A Daiichi Sankyo Inc.
Route N/A ORAL
Marketing Status N/A Discontinued